Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • pablo12
    Junior Member
    • Mar 2018
    • 1

    NGS-Ig data

    Dear users,

    I'd like to ask you for your advise on a certain project that I am working on.

    My job is to retrospectively analyse NGS data from patients suffering from ALL and MM (IGH).
    However, I am not a bioinformatician. I just received the sequencing data in Excel (and .csv) files and I'm supposed to analyse these data.

    Of course, I've heard of IMGT/VQUEST and IgBlast and it is no problem for me to work with these programmes. But the issue is that I can't do this with tens of thousands of sequences.

    After further research, I came across the R tool tcR. It seems to be a well-done programme. Unfortunately, I always receive error messages when trying to integrate my files in it.

    I found out that it might be useful to convert my files into .txt files or to work with VDJ-tools, Immunoseq, mixcr or other tools. But I do not have access to these programmes or they require Linux (which I don't have; Windows).

    In addition, the sequencing data in my Excel files are not in fasta-format. But if I would change this by editing the sequences manually I'd be busy for the next three months.

    My goal is to analyse my data for gene usage and to be able to search quickly for potential subclones.


    I look forward to hearing your opinion!
    Thanks in advance!

    Pablo
    Last edited by pablo12; 03-31-2018, 08:00 AM.
  • colindaven
    Senior Member
    • Oct 2008
    • 417

    #2
    You can probably use the sequences from the CSV files to create fasta files with a bit of creativity.

    Have a look at good text editors like Notepad++ to get this done.

    Also check out Galaxy for user friendly processing tools.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Working...